Los Angeles Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 526 shares of REGN stock, worth $373,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
526
Previous 1,760
70.11%
Holding current value
$373,460
Previous $1.85 Million
79.78%
% of portfolio
0.0%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding REGN
# of Institutions
1,484Shares Held
83.7MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.62 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.32 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.48 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.05 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...